Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.

Gynecologic oncology - 1 Jan 2022

John Catherine S, Fong Abigail, Alban Rodrigo, Gillen Jessica, Moore Kathleen M, Walsh Christine S, Li Andrew J, Rimel B J, Amersi Farin, Cass Ilana

Abstract excerpt

OBJECTIVES: BRCA 1 or 2 mutation carriers have increased risk of developing breast cancer (BC) and serous epithelial ovarian cancer (EOC). The incidence of BC over time after EOC is unknown. Optimal BC surveillance for BRCA mutation carriers following EOC has not been defined. METHODS: A multi-institutional retrospective chart review was performed. Patients with BRCA -associated EOC diagnosed between 1996 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Early Detection of Cancer

Share to Electronic Health Records

Share to Incidence

Share to Mammography

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 34862065
DOI: 10.1016/j.ygyno.2021.10.077

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.PMID 34862065Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Breast cancer following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.Semantic proximity Read ↗

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.Semantic proximity Read ↗

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.Semantic proximity Read ↗

Surgical management of BRCA-mutation carriers: A single institution experience.Semantic proximity Read ↗

Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

Risk reducing Salpingo-Oophorectomy in Patients with gBRCA-mutated Breast CancerSemantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.